CoChat

Different cardiovascular effects of progestins according to structure and activity

Nath, A., Sitruk-Ware, R. · 2009 · Climacteric

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Following the publication of the Women's Health Initiative study, the controversy was raised regarding the role of progestins in hormonal replacement therapy (HRT). Some of the most prescribed molecules, with partial androgenic or glucocorticoid activity, have been shown to oppose partially the beneficial effect of estrogens on surrogate markers of cardiovascular disease risk. Unfortunately, this concern has been directed towards progestins as a class effect, although striking differences exist among the types of molecules used. The synthetic progestins used in HRT have varying pharmacologic properties depending on the molecules from which they are derived, either testosterone or progesterone. Very small structural changes in these molecules may induce considerable difference in their effects on various targets and especially on the surrogate markers of cardiovascular disease risk, where some molecules may reverse the beneficial effects of estrogen. Natural progesterone and some of its derivatives such as the 19-norprogesterone molecules or the new molecules drospirenone, a potent antimineralocorticoid agent with a beneficial effect on blood pressure, and dienogest do not exert any androgenic effect and have no negative effect on the lipids or on the endothelial cells. Although it is likely that the new progestins may be neutral on the coronary disease risk, when administered to the younger postmenopausal woman, this has not as yet been documented by large, randomized, contro…

Overview

Integrity signals

Registry

Crossref · 10.1080/13697130902905757

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 19 references

Research works printed but not linked: 2

  1. Zerr-Fouineau M, 2008, Arterioscler Thromb Vasc Biol
  2. Arnal J F, 2009, Arterioscler Thromb Vasc Biol

Cited by

See all 46

Metadata

Authors
Nath, A., & Sitruk-Ware, R.
Affiliations
Population Council (US)
Venue
Climacteric
Published
2009-01
Volume
12
Issue
sup1
Pages
96-101
ISSN
  • 1369-7137 (ISSN-L)
  • 1473-0804
OpenAlex
W2093126216
Cited by
46
References
19
Citations by year
2025: 2 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 4 · 2018: 1 · 2017: 1 · 2015: 6 · 2014: 3 · 2013: 4 · 2012: 6
FWCI
3.15
Type
journal article
Language
en
Open access
closed
Locations
  • Climacteric (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
progestins, cardiovascular risk, hormone replacement therapy, Women's Health Initiative, androgenic activity, glucocorticoid activity, natural progesterone, 19-norprogesterone, drospirenone, dienogest, postmenopausal women, coronary artery disease, blood pressure, lipid profile, endothelial cells
MeSH terms
Animals, Cardiovascular Diseases, Female, Humans, Menopause, Risk Factors, Structure-Activity Relationship, Estrogen Replacement Therapy, Models, Animal, Progesterone Congeners

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Different cardiovascular effects of progestins according to structure and activity. https://app.cochat.ai/papers/10.1080/13697130902905757
The paper
Nath, A., & Sitruk-Ware, R. (2009). Different cardiovascular effects of progestins according to structure and activity. Climacteric. https://doi.org/10.1080/13697130902905757

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.